BROE CAPI Share Price

BCAC

US11374E1047

Days

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

Brookline Capital Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any industry or sector, it intends to source, acquire and manage a business in the life sciences industry. The Company has not conducted any operations and has not generated any revenues.

Employees

Sector

More about the company

18/08/22	Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
29/07/22	Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) dropped from NASDAQ Composite Index	CI
28/07/22	Apexigen Inc. completed the acquisition of Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others in a reverse merger transaction.	CI
23/05/22	Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
01/05/22	Brookline Capital Acquisition Corp. announced that it has received $0.167032 million in funding from Brookline Capital Holdings, LLC	CI
07/04/22	Brookline Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
06/04/22	Brookline Capital Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
18/03/22	Blank Check Firm Brookline Capital Acquisition, Apexigen Enter Merger Agreement	MT
17/03/22	Apexigen Inc. entered into a non-binding letter of intent to acquire Brookline Capital Acquisition Corp. from Brookline Capital Holdings, LLC, Periscope Capital Inc, Kepos Capital LP and others for approximately $210 million in a reverse merger transaction.	CI
16/08/21	Brookline Capital Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
26/07/21	Certain Common Stock of Brookline Capital Acquisition Corp. are subject to a Lock-Up Agreement Ending on 27-JUL-2021.	CI
07/06/21	Brookline Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
23/02/21	Brookline Capital Acquisition Corp.(NasdaqCM:BCAC) added to NASDAQ Composite Index	CI

18/08/22	BROE CAPI27 : INDEX TO UNAUDITED CONDENSED FINANCIAL STATEMENTS - Form 8-K/A	PU
04/08/22	BROE CAPI27 : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	PU
01/08/22	Brookline Capital Acquisition : Apexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company - Form 8-K	PU
28/07/22	BROOKLINE CAPITAL ACQUISITION : AND APEXIGEN, INC. ANNOUNCE STOCKHOLDER APPROVAL OF BUSINESS COMBINATION - Form 8-K	PU
18/07/22	Brookline Capital Acquisition : Apexigen and Brookline Capital Acquisition Corp. Announce Effectiveness of Registration Statement and Annual Stockholder Meeting to Approve the Proposed Business Combination - Form 8-K	PU

BROE CAPI Share Price

Stocks

BCAC

US11374E1047

Latest news : BROE CAPI

Press Releases: BROE CAPI

Quotes and Performance

Latest insider transactions

Company Profile